https://orcid.org/0000-0002-7999-8576
References
- Alarcon JB, Waine GW, McManus DP. DNA vaccines: technology and application as anti-parasite and anti-microbial agents. In: Baker JR, Muller R, and Rollinson D, editors. Advances in parasitology. Vol. 42. Cambridge (MA): Academic Press; 1999. p. 343–10.
- Robinson HL, Pertmer TM. DNA vaccines for viral infections: basic studies and applications. In: K. Maramorosch K, Murphy FA, and Shatkin AJ, editors. Advances in virus research. Vol. 55. Cambridge (MA): Academic Press; 2000. p. 1–74.
- Sunohara S, Asakura T, Kimura T, Ozawa S, Oshima S, Yamauchi D, Tamakoshi A. Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan. PLOS ONE. 2021;16:e0257107. doi:10.1371/journal.pone.0257107.
- Mackenzie JS, Smith DW, Mackenzie JS, Smith DW. COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t. Microbiol Aust. 2020;41:45–50. doi:10.1071/MA20013.
- Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg Open. 2020;76:71–76. doi:10.1016/j.ijsu.2020.02.034.
- Chan E-Y-Y, Cheng CK-Y, Tam GC-H, Huang Z, Lee PY. Willingness of future A/H7N9 influenza vaccine uptake: a cross-sectional study of Hong Kong community. Vaccine. 2015;33:4737–40. doi:10.1016/j.vaccine.2015.07.046.
- Wibawa T. COVID-19 vaccine research and development: ethical issues. Trop Med Int Health. 2021;26:14–19. doi:10.1111/tmi.13503.
- CDC. Different COVID-19 Vaccines. Centers for Disease Control and Prevention; 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines.html.
- COVID-19 vaccines. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines.
- Draft landscape and tracker of COVID-19 candidate vaccines. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.
- Zhu H, Wei L, Niu P. The novel coronavirus outbreak in Wuhan, China. Global Health Res Policy. 2020;5:6. doi:10.1186/s41256-020-00135-6.
- Li Z, Chen Q, Feng L, Rodewald L, Xia Y, Yu H, Zhang R, An Z, Yin W, Chen W, et al. Active case finding with case management: the key to tackling the COVID-19 pandemic. Lancet. 2020;396:63–70. doi:10.1016/S0140-6736(20)31278-2.
- Le TT, Cramer JP, Chen R, Mayhew S. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19:305–06. doi:10.1038/d41573-020-00151-8.
- Mainoli B, Machado T, Duarte GS, Prada L, Gonçalves N, Ferreira JJ, Costa J. Analysis of clinical and methodological characteristics of early COVID-19 treatment clinical trials: so much work, so many lost opportunities. BMC Med Res Methodol. 2021;21:42. doi:10.1186/s12874-021-01233-w.
- Deutsche Welle. COVID-19 vaccine development: what’s the progress? | DW | 11.03.2021. DW.COM. https://www.dw.com/en/covid-19-vaccine-development-whats-the-progress/a-55648707.
- COVID-19 world vaccination progress. https://kaggle.com/gpreda/covid-world-vaccination-progress.
- Population by Country - 2020. https://kaggle.com/tanuprabhu/population-by-country-2020.
- Dey SK, Rahman MM, Siddiqi UR, Howlader A. Analyzing the epidemiological outbreak of COVID-19: a visual exploratory data analysis approach. J Med Virol. 2020;92:632–38. doi:10.1002/jmv.25743.
- Islam S Md., Siddique AB, Akter R, Tasnim R, Sujan MSH, Ward PR, Sikder MT. Knowledge, attitudes and perceptions towards COVID-19 vaccinations: a cross-sectional community survey in Bangladesh. BMC Public Health. 2021;21:1851. doi:10.1186/s12889-021-11880-9.
- Authorized vaccines. https://www.covid-19vaccinetracker.org/authorized-vaccines.
- Huang H-Y, Wang S-H, Tang Y, Sheng W, Zuo C-J, Wu D-W, Fang H, Du Q, Li N. Landscape and progress of global COVID-19 vaccine development. Hum Vaccin Immunother. 2021;17:3276–80. doi:10.1080/21645515.2021.1945901.
- Buchy P, Buisson Y, Cintra O, Dwyer DE, Nissen M, Ortiz de Lejarazu R, Petersen E. COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control. Int J Infect Dis. 2021;112:300–17. doi:10.1016/j.ijid.2021.09.045.
- ElBagoury M, Tolba MM, Nasser HA, Jabbar A, Elagouz AM, Aktham Y, Hutchinson A. The find of COVID-19 vaccine: challenges and opportunities. J Infect Public Health. 2021;14:389–416. doi:10.1016/j.jiph.2020.12.025.
- Calina D, Docea A, Petrakis D, Egorov A, Ishmukhametov A, Gabibov A, Shtilman M, Kostoff R, Carvalho F, Vinceti M, et al. Towards effective COVID‑19 vaccines: updates, perspectives and challenges (Review). Int J Mol Med. 2020;46(1):3–16. doi:10.3892/ijmm.2020.4596.
- Kashte S, Gulbake A, El-Amin SF III, Gupta A. COVID-19 vaccines: rapid development, implications, challenges and future prospects. Hum Cell. 2021;34:711–33. doi:10.1007/s13577-021-00512-4.